Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-12-27A Phase 1/2, Multicenter, Open-label, Dose-finding Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent or Refractory Solid Tumors.
-
CLINICAL_TRIALS study record update · 2018-12-19Skin Care Behaviors Among Melanoma Survivors and Their Families
-
CLINICAL_TRIALS study record update · 2018-11-20Circulating Tumor DNA Exposure in Peripheral Blood Using a Novel Process: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2018-11-16Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention (SBIR Topic 342, Direct to Phase II- Vignet, Inc.)
-
CLINICAL_TRIALS study record update · 2018-11-14A Phase I Study of Temozolomide, Thalidomide, and Lomustine (TTL) in Patients With Metastatic Melanoma in the Brain
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-11-09A Parallel Phase I/II Study of Low Dose Decitabine (5-Aza-Deoxycytidine) With Peginterferon Alfa-2b in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2018-11-07Analysis of the Kinetics and Effects of Vemurafenib + Cobimetinib on Intratumoral and Host Immunity in Patients With Advanced BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy
-
CLINICAL_TRIALS study record update · 2018-10-31Phase II Trial of Gleevec (Imatinib Mesylate, STI-571) in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2018-10-17A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Vemurafenib (RO5185426) Adjuvant Therapy in Patients With Surgically Resected, Cutaneous BRAF-Mutant Melanoma at High Risk for Recurrence
-
CLINICAL_TRIALS study record update · 2018-10-16ClinicalTrials.gov study NCT01666418
-
CLINICAL_TRIALS study record update · 2018-10-09A Phase 2, Randomized, Open-Label Study of Infliximab and Lower Exposure Corticosteroids vs Methylprednisolone and Higher Exposure Oral Corticosteroids for the Management of Immune-Related Severe or Persistent Diarrhea in Patients Treated With Yervoy (Ipilimumab) and/or Opdivo (Nivolumab)
-
CLINICAL_TRIALS study record update · 2018-10-03A Phase I, Open-label, Multi-arm, Multi-centre, Multi-dose, Dose Escalation Study of LTX-315 as Monotherapy or in Combination With Either Ipilimumab or Pembrolizumab in Patients With Transdermally Accessible Tumours
-
CLINICAL_TRIALS study record update · 2018-09-26COMBI-AD: A Phase III Randomized Double Blind Study of Dabrafenib (GSK2118436) in COMBInation With Trametinib (GSK1120212) Versus Two Placebos in the ADjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma After Surgical Resection
-
CLINICAL_TRIALS study record update · 2018-09-19Phase 1/2 Study Epigenetic Modification of BRAF-mutated Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib
-
CLINICAL_TRIALS study record update · 2018-09-14A Phase I Study to Evaluate the Pharmacokinetics and Safety of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib With Trametinib in Chinese Subjects With Melanoma
-
CLINICAL_TRIALS study record update · 2018-09-13Dermoscopy Evaluation of Pigmented Skin Lesions by a Neuronal Network Clinical Decision Support: an Open Prospective Non Interventional Study
-
CLINICAL_TRIALS study record update · 2018-09-12A Study of Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2018-09-07GSK2132231A Antigen-Specific Cancer Immunotherapeutic as First-line Treatment of Patients With Unresectable Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2018-08-31A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of BCD-100 (JSC BIOCAD, Russia) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-08-31Study of GSK2302025A Antigen-Specific Cancer Immunotherapeutic in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2018-08-28Vaccination of Chemotherapy Induced Lymphopenic Unresectable Stage III or Stage IV Melanoma Patients Following Reconstitution With Total or CD25-depleted PBMC
-
CLINICAL_TRIALS study record update · 2018-08-28Neoadjuvant Combination Biotherapy With Ipilimumab (3 mg/kg or 10 mg/kg) and High Dose IFN-Α2B in Patients With Locally/Regionally Advanced/Recurrent Melanoma: a Randomized Safety, Efficacy and Biomarker Study
-
CLINICAL_TRIALS study record update · 2018-08-20Long-term Follow-up of Survival in Surgical Resected Invasive Cutaneous Melanomas: Comparing 2-cm Versus 4 -cm Resection Margins - a Randomized, Multicenter Trial
-
CLINICAL_TRIALS study record update · 2018-07-17A Randomized Phase 3 Study of Tasisulam-sodium Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle Versus Paclitaxel as Second-line Treatment in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2018-07-09SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access